Cargando…

The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations

Fear of hypoglycemia is a common barrier to exercise and physical activity for individuals with type 1 diabetes. While some of the earliest studies in this area involved only one or two participants, the link between exercise, exogenous insulin, and hypoglycemia was already clear, with the only sugg...

Descripción completa

Detalles Bibliográficos
Autor principal: Yardley, Jane E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902845/
https://www.ncbi.nlm.nih.gov/pubmed/31827338
http://dx.doi.org/10.2147/OAJSM.S149257
_version_ 1783477744702586880
author Yardley, Jane E
author_facet Yardley, Jane E
author_sort Yardley, Jane E
collection PubMed
description Fear of hypoglycemia is a common barrier to exercise and physical activity for individuals with type 1 diabetes. While some of the earliest studies in this area involved only one or two participants, the link between exercise, exogenous insulin, and hypoglycemia was already clear, with the only suggested management strategies being to decrease insulin dosage and/or consume carbohydrates before and after exercise. Over the past 50 years, a great deal of knowledge has been developed around the impact of different types and intensities of exercise on blood glucose levels in this population. Recent decades have also seen the development of technologies such as continuous glucose monitors, faster-acting insulins and commercially available insulin pumps to allow for the real-time observation of interstitial glucose levels, and more precise adjustments to insulin dosage before, during and after activity. As such, there are now evidence-based exercise and physical activity guidelines for individuals with type 1 diabetes. While the risk of hypoglycemia has not been completely eliminated, therapy recommendations have evolved considerably. This review discusses the evolution of the knowledge and the technology related to type 1 diabetes and exercise that have allowed this evolution to take place.
format Online
Article
Text
id pubmed-6902845
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69028452019-12-11 The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations Yardley, Jane E Open Access J Sports Med Review Fear of hypoglycemia is a common barrier to exercise and physical activity for individuals with type 1 diabetes. While some of the earliest studies in this area involved only one or two participants, the link between exercise, exogenous insulin, and hypoglycemia was already clear, with the only suggested management strategies being to decrease insulin dosage and/or consume carbohydrates before and after exercise. Over the past 50 years, a great deal of knowledge has been developed around the impact of different types and intensities of exercise on blood glucose levels in this population. Recent decades have also seen the development of technologies such as continuous glucose monitors, faster-acting insulins and commercially available insulin pumps to allow for the real-time observation of interstitial glucose levels, and more precise adjustments to insulin dosage before, during and after activity. As such, there are now evidence-based exercise and physical activity guidelines for individuals with type 1 diabetes. While the risk of hypoglycemia has not been completely eliminated, therapy recommendations have evolved considerably. This review discusses the evolution of the knowledge and the technology related to type 1 diabetes and exercise that have allowed this evolution to take place. Dove 2019-12-06 /pmc/articles/PMC6902845/ /pubmed/31827338 http://dx.doi.org/10.2147/OAJSM.S149257 Text en © 2019 Yardley. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Yardley, Jane E
The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
title The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
title_full The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
title_fullStr The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
title_full_unstemmed The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
title_short The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
title_sort athlete with type 1 diabetes: transition from case reports to general therapy recommendations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902845/
https://www.ncbi.nlm.nih.gov/pubmed/31827338
http://dx.doi.org/10.2147/OAJSM.S149257
work_keys_str_mv AT yardleyjanee theathletewithtype1diabetestransitionfromcasereportstogeneraltherapyrecommendations
AT yardleyjanee athletewithtype1diabetestransitionfromcasereportstogeneraltherapyrecommendations